Cargando…

Safety and efficacy of an interleukin 12/23 inhibitor in a patient with constitutional neutropenia and psoriasis vulgaris()()

Detalles Bibliográficos
Autores principales: Starek, Jéssica Vianna, Bechara, Cristina Santos Ribeiro, Dultra, Mariana Reis e Rocha, Krakheche, Juliana de Morais Fernandes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790215/
https://www.ncbi.nlm.nih.gov/pubmed/34544636
http://dx.doi.org/10.1016/j.abd.2020.11.010
_version_ 1784639945926770688
author Starek, Jéssica Vianna
Bechara, Cristina Santos Ribeiro
Dultra, Mariana Reis e Rocha
Krakheche, Juliana de Morais Fernandes
author_facet Starek, Jéssica Vianna
Bechara, Cristina Santos Ribeiro
Dultra, Mariana Reis e Rocha
Krakheche, Juliana de Morais Fernandes
author_sort Starek, Jéssica Vianna
collection PubMed
description
format Online
Article
Text
id pubmed-8790215
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-87902152022-02-01 Safety and efficacy of an interleukin 12/23 inhibitor in a patient with constitutional neutropenia and psoriasis vulgaris()() Starek, Jéssica Vianna Bechara, Cristina Santos Ribeiro Dultra, Mariana Reis e Rocha Krakheche, Juliana de Morais Fernandes An Bras Dermatol Case Letter Sociedade Brasileira de Dermatologia 2021 2021-09-17 /pmc/articles/PMC8790215/ /pubmed/34544636 http://dx.doi.org/10.1016/j.abd.2020.11.010 Text en © 2021 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Letter
Starek, Jéssica Vianna
Bechara, Cristina Santos Ribeiro
Dultra, Mariana Reis e Rocha
Krakheche, Juliana de Morais Fernandes
Safety and efficacy of an interleukin 12/23 inhibitor in a patient with constitutional neutropenia and psoriasis vulgaris()()
title Safety and efficacy of an interleukin 12/23 inhibitor in a patient with constitutional neutropenia and psoriasis vulgaris()()
title_full Safety and efficacy of an interleukin 12/23 inhibitor in a patient with constitutional neutropenia and psoriasis vulgaris()()
title_fullStr Safety and efficacy of an interleukin 12/23 inhibitor in a patient with constitutional neutropenia and psoriasis vulgaris()()
title_full_unstemmed Safety and efficacy of an interleukin 12/23 inhibitor in a patient with constitutional neutropenia and psoriasis vulgaris()()
title_short Safety and efficacy of an interleukin 12/23 inhibitor in a patient with constitutional neutropenia and psoriasis vulgaris()()
title_sort safety and efficacy of an interleukin 12/23 inhibitor in a patient with constitutional neutropenia and psoriasis vulgaris()()
topic Case Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790215/
https://www.ncbi.nlm.nih.gov/pubmed/34544636
http://dx.doi.org/10.1016/j.abd.2020.11.010
work_keys_str_mv AT starekjessicavianna safetyandefficacyofaninterleukin1223inhibitorinapatientwithconstitutionalneutropeniaandpsoriasisvulgaris
AT becharacristinasantosribeiro safetyandefficacyofaninterleukin1223inhibitorinapatientwithconstitutionalneutropeniaandpsoriasisvulgaris
AT dultramarianareiserocha safetyandefficacyofaninterleukin1223inhibitorinapatientwithconstitutionalneutropeniaandpsoriasisvulgaris
AT krakhechejulianademoraisfernandes safetyandefficacyofaninterleukin1223inhibitorinapatientwithconstitutionalneutropeniaandpsoriasisvulgaris